Title |
Treatment of critical-sized bone defects: clinical and tissue engineering perspectives
|
---|---|
Published in |
European Journal of Orthopaedic Surgery & Traumatology, October 2017
|
DOI | 10.1007/s00590-017-2063-0 |
Pubmed ID | |
Authors |
Erika Roddy, Malcolm R. DeBaun, Adam Daoud-Gray, Yunzhi P. Yang, Michael J. Gardner |
Abstract |
Critical-sized bone defects are defined as those that will not heal spontaneously within a patient's lifetime. Current treatment options include vascularized bone grafts, distraction osteogenesis, and the induced membrane technique. The induced membrane technique is an increasingly utilized method with favorable results including high rates of union. Tissue engineering holds promise in the treatment of large bone defects due to advancement of stem cell biology, novel biomaterials, and 3D bioprinting. In this review, we provide an overview of the current operative treatment strategies of critical-sized bone defects as well as the current state of tissue engineering for such defects. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 412 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 64 | 16% |
Student > Bachelor | 52 | 13% |
Student > Master | 46 | 11% |
Researcher | 29 | 7% |
Student > Doctoral Student | 19 | 5% |
Other | 52 | 13% |
Unknown | 150 | 36% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 67 | 16% |
Engineering | 67 | 16% |
Biochemistry, Genetics and Molecular Biology | 33 | 8% |
Materials Science | 31 | 8% |
Agricultural and Biological Sciences | 11 | 3% |
Other | 36 | 9% |
Unknown | 167 | 41% |